Cell and gene therapy (CGT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. GenScript ProBio develops and manufactures CAR-T plasmid of any size and for a wide range of application. Following the new drug development process, GMP plasmid production in different quality levels are provided to meet requirements in different stages with rapid turn-around time and 100% on-time delivery rate.
GenScript ProBio-Accelerating Vaccine Development against COVID-19
GenScript ProBio-Plasmid DNA Production for the Development of mRNA Therapy
LentiHelper™ Plasmid products are immediately available for packaging the 3rd generation lentiviral vector, to support pre-clinical and clinical phases’ needs.
Adopting most relevant GMP features, ProPlasmid™ fulfills your expectation in pre-IND phases and bring your projects through non-clinical stages cost-effectively.
GenScript ProBio provides our clients with GMPro™ plasmid under comprehensive quality assurance to meet your needs in early stage clinical. Get your project started now without waiting!
Plasmid Process Development Center, Zhenjiang, CN